IRIS
SCHWARTZ, PETER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.750
EU - Europa 8.908
AS - Asia 6.792
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 16
SA - Sud America 7
Totale 28.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.627
CN - Cina 6.603
IE - Irlanda 2.589
UA - Ucraina 2.005
DE - Germania 1.171
FI - Finlandia 922
SE - Svezia 867
IT - Italia 657
GB - Regno Unito 399
FR - Francia 146
CA - Canada 119
SG - Singapore 99
RU - Federazione Russa 52
BE - Belgio 39
IN - India 33
MU - Mauritius 31
NL - Olanda 29
JP - Giappone 27
EU - Europa 17
IR - Iran 17
AU - Australia 13
ES - Italia 13
CL - Cile 4
HU - Ungheria 4
MX - Messico 4
MY - Malesia 3
NZ - Nuova Zelanda 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GR - Grecia 2
IQ - Iraq 2
SA - Arabia Saudita 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BY - Bielorussia 1
CO - Colombia 1
EG - Egitto 1
ET - Etiopia 1
HK - Hong Kong 1
ID - Indonesia 1
LU - Lussemburgo 1
LV - Lettonia 1
PK - Pakistan 1
VN - Vietnam 1
Totale 28.524
Salva come PNG Salva come JPEG
Città #
Chandler 2.644
Jacksonville 2.587
Dublin 2.585
Nanjing 2.096
Boardman 888
Ashburn 855
Nanchang 850
Princeton 640
Lawrence 603
Shenyang 593
Hebei 571
Wilmington 559
Changsha 558
Jiaxing 510
Medford 408
Tianjin 324
Hangzhou 310
Beijing 285
Helsinki 212
Ann Arbor 195
Woodbridge 148
Milan 130
Norwalk 112
Shanghai 111
Verona 111
Fairfield 61
Toronto 59
Houston 54
Kunming 54
New York 53
Pavia 53
Mcallen 52
Seattle 51
Singapore 50
Des Moines 47
Washington 45
Los Angeles 44
Falls Church 42
Munich 39
Montréal 37
Ningbo 35
Brussels 34
Zhengzhou 34
Jinan 33
Tokyo 26
Dearborn 23
Fuzhou 22
Lanzhou 19
Pune 19
Guangzhou 18
Orange 18
Rome 17
San Genesio Ed Uniti 17
Tappahannock 17
Chicago 16
Taizhou 16
Changchun 15
Berlin 14
Nuremberg 14
Auburn Hills 13
Borås 13
Chieti 10
Dallas 9
Pescara 8
Redwood City 8
Rochester 8
Catanzaro 7
Madrid 7
San Francisco 7
Bari 6
Mountain View 6
Falkenstein 5
Frankfurt am Main 5
Melbourne 5
Monmouth Junction 5
Napoli 5
Padova 5
Palermo 5
Saint Petersburg 5
Saint-herblain 5
St Petersburg 5
Tübingen 5
Walnut 5
Zola Predosa 5
Bastia umbra 4
Florence 4
Hefei 4
Jinhua 4
Kansas City 4
Kingston 4
Legnaro 4
Leuven 4
Mexico City 4
Piscataway 4
Rockville 4
Szeged 4
Van Nuys 4
Vancouver 4
Villalvernia 4
Weinan 4
Totale 20.264
Salva come PNG Salva come JPEG
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 220
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 215
Calcio antagonisti e aritmie da riperfusione miocardica 138
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 100
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 94
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 88
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 86
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 85
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 85
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 83
[Sympathetic reflex induced by experimental coronary occlusion]. 83
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 80
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 80
FGF12 is a candidate Brugada syndrome locus. 80
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 80
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 78
Mortalità infantile e morte improvvisa in culla in Lombardia 78
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 77
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 75
The ICD for the long QT syndrome: which indications, complications, and results? 75
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 74
Alpha 1-adrenergic blockade and sudden cardiac death. 74
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 74
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 74
Risk stratification in the Long-QT Syndrome 73
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 73
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 72
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 71
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 71
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 71
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 70
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 70
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 70
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 69
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 69
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 69
A sympathetic reflex elicited by experimental coronary occlusion. 69
All LQT3 patients need an ICD. True or false? 68
Sertraline treatment of major depression in patients with acute MI or unstable angina. 68
QT prolongation and sudden infant death syndrome - from theory to evidence. 68
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 67
THE SUDDEN INFANT DEATH SYNDROME: CARDIO-RESPIRATORY MECHANISMS AND INTERVENTIONS. 67
Congenital long QT and short QT syndromes 67
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 66
The long QT syndrome. Prospective longitudinal study of 328 families. 66
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 66
Cardiac sodium channel dysfunction in sudden infant death syndrome. 66
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. 66
[Infant mortality and sudden crib death in Lombardy]. 66
Adrenergic Arrhythmogenesis and The Long QT syndrome 66
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 66
Task Force Report: The legal implications of medical guidelines - a Task Force of the European Society of Cardiology 65
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 65
Cost effectiveness of neonatal ECG screening for the long QT syndrome: reply. 65
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 65
Inherited cardiac arrhythmia syndrome. Role of potassium channels 64
QT lungo, sindrome del 64
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 64
Cardiac potassium channel dysfunction in sudden infant death syndrome. 64
on Behalf of the Azimilide Trials Investigators: Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database 63
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 63
An experimental approach to the choice of antiarrhythmic therapy. 63
Multiple mechanisms of Na+ channel--linked long-QT syndrome. 63
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 63
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 63
Prevalence of the congenital long-QT syndrome. 63
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes 62
Nuovi rischi medico-legali per il cardiologo: la cardiologia molecolare ed il caso della sindrome del QT lungo. 62
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)]. 62
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 62
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 62
Significance of Qt dispersion in the long QT syndrome 61
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 61
Gene symbol: SCN5A 61
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 61
Can a message from the dead save lives? 61
The quest for the mechanism of the sudden infant death syndrome. Doubts and progress 60
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 60
The RecordAF Study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation 60
Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. 60
Progress in the evaluation of a new class I antiarrhythmic agent: Penticainide 60
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? 60
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 60
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 60
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 60
Two-to-one AV block associated with the congenital QT syndrome 59
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. 59
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias 59
[Cardio-cardiac sympathico-vagal reflex]. 59
Vagal stimulation for heart failure 59
Genetic testing for the long QT syndrome: who and why? Insights for clinical management. 59
A cardiac murmur depending on the Wolff-Parkinson-White syndrome. 59
Autonomic nervous system: emerging concepts and clinical applications. 58
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 58
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 58
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease. 58
Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. 58
Unilateral stellectomy and dysrhythmias. 58
The long QT syndrome: a clinical counterpart of hERG mutations. 58
Cardiac arrhythmias in infancy: prevalence, significance and need for treatment. 58
Totale 7.115
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.509
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.684 0 3.502 9 387 8 432 28 451 13 553 262 39
2020/20213.657 437 345 108 376 36 486 11 569 117 560 503 109
2021/20222.401 31 10 72 28 34 176 30 129 173 67 390 1.261
2022/20237.639 921 455 58 608 836 888 6 456 3.103 34 170 104
2023/20242.416 259 528 108 197 280 647 52 128 7 67 69 74
2024/2025767 120 647 0 0 0 0 0 0 0 0 0 0
Totale 28.801